Eccrine Poroma — Trials

Eccrine Poroma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07301424	Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL	not yet recruiting	Phase 2	80	University of AlbertaOTHER	1	Aug 12, 2026	clinicaltrials
NCT07152041	Newly-diagnosed Pediatric Ph-positive B-ALL Protocol(CAMS-Ph+ B-ALL)	recruiting	Phase 3	150	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	2	Sep 3, 2025	clinicaltrials
NCT01131325	Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations(MACS1148)	terminated	Phase 4	3	Novartis PharmaceuticalsINDUSTRY	1	May 20, 2021	clinicaltrials
NCT01221376

Data updated 22 days agoSource updated Aug 12, 2026source: clinicaltrials